The Conversation (0)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Greenrose Acquisition Corp. ("Greenrose" or the "Company") (OTCMKTS:GNRS). Investors who purchased Greenrose sharesare encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.comgnrs
The investigation concerns whether Greenrose and certain of its officers and/or directors have violated federal securities laws.
On November 24, 2021, post-market, Greenrose disclosed in a U.S. Securities and Exchange Commission filing that "[i]n connection with the preparation of its financial statements as of September 30, 2021, [Greenrose's management] has re-evaluated the Company's application of ASC 480-10-S99 to its accounting classification of the redeemable shares of common stock, par value $0.0001 per share (the ‘Public Shares'), issued as part of the units sold in the Company's initial public offering (the ‘IPO') on February 13, 2020. Historically, a portion of the Public Shares was classified as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that the Company will consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001. Pursuant to such re-evaluation, the Company's management has determined that the Public Shares include certain provisions that require classification of the Public Shares as temporary equity regardless of the minimum net tangible assets required to complete the Company's initial business combination." Accordingly, Greenrose advised that certain of the Company's financial statements would need to be restated and should no longer be relied upon, and that "[t]he Company's management has concluded that in light of the classification error described above, a material weakness exists in the Company's internal control over financial reporting and that the Company's disclosure controls and procedures were not effective[.]" On this news, Greenrose's stock price fell $1.84 per share, or 20.13%, over the following two trading sessions, to close at $7.30 per share on November 29, 2021.
If you are aware of any facts relating to this investigation or purchased Greenrose shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/gnrs. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz and Grossman, LLC
View source version on accesswire.com:
https://www.accesswire.com/675629/Bronstein-Gewirtz-Grossman-LLC-Notifies-Shareholders-of-Greenrose-Acquisition-Corp-GNRS-Investigation
View original content to download multimedia: 
View original content to download multimedia: 
View original content to download multimedia: 
View original content to download multimedia: 
